Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Silver

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
Hematology/Oncology Clinics of North America|April 1, 1990
Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phaseR T Silver
Hematology/Oncology Clinics of North America|October 17, 2003
Chronic myeloid leukemiaRichard T Silver
Current Hematology Reports|May 4, 2005
Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylateRichard T Silver
Blood|August 15, 1990
A new treatment for polycythemia vera: recombinant interferon alfaR T Silver
Current Opinion in Oncology|February 1, 1992
Chronic myeloid leukemiaR T Silver
Cancer|June 29, 2006
Long-term effects of the treatment of polycythemia vera with recombinant interferon-alphaRichard T Silver
The Oncologist|April 1, 2011
Predictive value of in vitro mutation data to guide second-generation tyrosine kinase inhibitor selection: ready for prime time?Richard T Silver
Seminars in Hematology|July 1, 1990
Interferon in the treatment of myeloproliferative diseasesR T Silver
Leukemia|October 29, 2004
Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemiaR T Silver
Best Practice & Research. Clinical Haematology|December 5, 2009
The blast phase of chronic myeloid leukaemiaRichard T Silver
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
Hematology/Oncology Clinics of North America|April 1, 1990
Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phaseR T Silver
Hematology/Oncology Clinics of North America|October 17, 2003
Chronic myeloid leukemiaRichard T Silver
Current Hematology Reports|May 4, 2005
Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylateRichard T Silver
Blood|August 15, 1990
A new treatment for polycythemia vera: recombinant interferon alfaR T Silver
Current Opinion in Oncology|February 1, 1992
Chronic myeloid leukemiaR T Silver
Cancer|June 29, 2006
Long-term effects of the treatment of polycythemia vera with recombinant interferon-alphaRichard T Silver
The Oncologist|April 1, 2011
Predictive value of in vitro mutation data to guide second-generation tyrosine kinase inhibitor selection: ready for prime time?Richard T Silver
Seminars in Hematology|July 1, 1990
Interferon in the treatment of myeloproliferative diseasesR T Silver
Leukemia|October 29, 2004
Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemiaR T Silver
Best Practice & Research. Clinical Haematology|December 5, 2009
The blast phase of chronic myeloid leukaemiaRichard T Silver
Pageof 24